Tag: Erelzi

According to the European Medicines Agency, Erelzi (etanercept) is a biosimilar drug used to treat various inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. The medication is administered via a subcutaneous injection, and proper technique is crucial for its safety and effectiveness. This guide provides detailed steps on how to administer Erelzi.

Did you know that in autoimmune diseases like rheumatoid arthritis and psoriasis, the immune system mistakenly attacks healthy tissues, causing chronic inflammation? Erelzi, a biosimilar of Enbrel, helps to manage this by specifically targeting and blocking a key inflammatory protein, offering a targeted approach to therapy.